Archives > December 2017

ACFP’s Top Ten for 2017

Read the full December eNews & President’s Message.

Looking back on 2017,  we invested in advocacy, leadership, and education while supporting you and your teams in the delivery of care for your patients. Here are my thoughts on the ACFP’s Top 10 over the past year:

  1. We established a task force of 12 family physician members that informed the ACFP Opioid Crisis Response and put forward a set of recommendations that was sent to all stakeholders in primary care delivery,
  2. We continue to build on and expand our Family Medicine Leadership Program aimed at providing “Leadership Development for Where You Are,”
  3. Together with the AHS and AMA, we developed a portal to Engage Primary Care physicians in clinical and system level projects. To date, we’ve successfully linked more than 50 family physicians to active projects,
  4. We successfully orchestrated our 62nd Annual Scientific Assembly (ASA) for nearly 400 delegates, highlighting relevant CPD topics, family medicine research, and recognition of excellence, while serving as a gathering of friends and colleagues in a pristine location in the Canadian Rockies,
  5. Our Practical Evidence for Informed Practice (PEIP) Conference hosted over 400 delegates on site, with another 225 joining by webcast, to learn about the best evidence and practice recommendations in over 19 clinical areas,
  6. This December, we published our 200th Tools for Practice article since the inception of our 2009 collaboration with the University of Alberta’s evidence based medicine team—PEER (Patients Experience Evidence Research)—led by Drs. Mike Allan, Mike Kolber, and Tina Korownyk. The ACFP’s Tools for Practice articles are sent to more than 32,000 family physicians and primary care providers in Canada and across the globe,
  7. The ACFP Awards and Recognition program recognized Dr. Donald Chan of Edmonton as the Family Physician of the Year and added a new award category to recognize Outstanding Family Practice Teams that deliver on the principles of the Patient’s Medical Home. Be sure to check out all of our 2017 award recipients,
  8. We worked hard to revitalize and recruit to our governance and operational committees which advise on and support the work of the ACFP. Sincere thanks to our many volunteers for their commitment to the profession—we couldn’t do it without you,
  9. Our Board of Directors has been focused on setting the strategic direction of the ACFP through ongoing deliberations and in-depth discussions, as well as providing oversight and support to the management and staff at the office. Our Board is both vital and well connected to the membership, building relationships at events and using those opportunities to find out what we can do to support you in your practices,
  10. We continue to collaborate with a variety of partners in the delivery and design of the health care system and continue to be known for our high road approach. Learn more about how we work with the other organizations in Alberta by checking out our “Understanding Who’s Who in Alberta’s Health Care” document.

I look forward to another momentous year of progress and potential! Contact me anytime if you have questions, input, or feedback.

 

 

Tools for Practice publishes 200th article!

With their recent article, “Harms of Medical Cannabinoids: Up in Smoke!” our Tools for Practice team celebrated their 200th article! For over eight years, this ACFP-supported team has been creating bi-weekly articles to summarize medical evidence on a clinical question, with a focus on information that can modify your day-to-day practice.

To celebrate this momentous occasion, we asked the team to tell us about their favourite article, or biggest accomplishment so far.

Mike Allan: Controversial ones like cannabinoids, vaccines, salt, etc., are often the ones I feel we need to do but I dislike doing as I get tired of tilting at beliefs. The first ones were educational and I think by year two we were really starting to improve the methods. Santa (#177) was the funnest.

Mike Kolber:

  1. Zostavax (#77) for its excellent review of why it’s important to look at absolute (not relative) benefits,
  2. Zamboni procedure for MS (#43) for shedding light on a non-beneficial therapy.

Tina Korownyk: My favourite is Motivating Patients to Move (#5) because it provided an easy recommendation for a tool (pedometer to track physical activity) to incorporate into practice that also provides tangible results for patients.

Adrienne Lindblad: This is tough. Here are my top 10 and my reasons:

  1. Aldosterone antagonists in HF (#104): It isn’t the best tool to read, but it was the first one I wrote and it definitely challenged my ideas of heart failure management, particularly around target doses,
  2. Flu shot (#99, 100): I loved the controversy over this one. Some people said “wow it works better than I thought!” while others said “wow this is terrible!”
  3. Santa (#177): It was fun and involved the whole group,
  4. Diclectin (#186): It was very interesting to research, particularly with the attention the media was paying to the topic,
  5. Salt (#86): I love the controversy and the sponsorship bias,
  6. Treating to target (#110): Because it was an idea of Mike’s and I never thought I would be able to write it,
  7. Antidepressant onset (#13): Because it changes our beliefs,
  8. Infant sleep (#196): Because I have three kids and I like knowing that I haven’t permanently screwed up my kids … at least not from sleep training them!
  9. MMR (#29): Because it made me really angry and highlights the importance of what we do,
  10. Zostavax (#77): The best example of knowing absolute vs relative benefits. It was short, simple, and memorable.

With a sample size of 200, the evidence is clear: family physicians find Tools for Practice valuable. But we want to hear from you! What has been your favourite article? How has Tools for Practice impacted you and/or your practice?

Let us know through Twitter (use the hashtag #ToolsForPractice), on Facebook (follow “Alberta College of Family Physicians”), or in the comments below.